TD Securities raised the firm’s price target on Extendicare (EXETF) to C$39 from C$32 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare initiated with a Buy at Desjardins
- Extendicare Declares April 2026 Monthly Dividend for Shareholders
- Extendicare Raises $450 Million in Debut Investment-Grade Note Offering
- Extendicare launches $450 million inaugural investment-grade notes to strengthen balance sheet
- Extendicare Sets Date for Q1 2026 Results and Investor Call